Thus, MCP may be considered and proposed as a novel target to reduce long-term renal injuries, attenuate renal fibrosis and preserve kidney function, possibly via the effect of Gal-3 on carbohydrate binding-related functions [325]. This evidence concerns the gene LGALS3 and renal fibrosis.